Hemangiosarcoma breakthrough in the fight against cancer

New drug improves survival rate in dogs.

University of Minnesota has announced the breakthrough trial of a new drug that improves survival rates in dogs diagnosed with a cancer called hemangiosarcoma (HSA). The research and results were published recently published in the journal of Molecular Cancer Therapeutics.

"This is likely the most significant advance in the treatment of canine HSA in the last three decades," said study co-author Jaime Modiano, V.M.D., Ph.D. professor in the University of Minnesota College of Veterinary Medicine and member of the Masonic Cancer Center, University of Minnesota. CLICK HERE for more details on this new drug trial, which is lauded to be the most significant breakthrough in 30 years.

© 2020 AllCityDogs.com All Rights Reserved.
Website developed by